DCF — TRINITY HEALTH ANN ARBOR
Enterprise Value: $-325.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-325.7M
Enterprise Value
$-130.8M
PV of Cash Flows
$-194.8M
PV of Terminal Value
$-313.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.0B | $-5.1M | -0.0% | $-48.7M | $-44.3M |
| Year 2 | $1.1B | $5.3M | 1.0% | $-39.6M | $-32.7M |
| Year 3 | $1.1B | $16.4M | 2.0% | $-29.8M | $-22.4M |
| Year 4 | $1.1B | $22.6M | 2.0% | $-25.1M | $-17.1M |
| Year 5 | $1.2B | $26.1M | 2.0% | $-23.0M | $-14.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-325.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.0B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.009965439204437798
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5